InvestorsHub Logo
Followers 17
Posts 1413
Boards Moderated 0
Alias Born 12/19/2017

Re: TradingThings4 post# 28270

Thursday, 04/30/2020 5:54:31 PM

Thursday, April 30, 2020 5:54:31 PM

Post# of 35961
The big question is what are the assets worth and who has bought these assets. They are well worth buying to so many large clients to get a drug with so much potential at phase 3 with orphan drug status. Yikes. Worth way more than this. However that only the way I see it. Hoping big Pharma does too. They have so many connections from previous activity. Just takes that one release and it’s off to the races for Nspx . Without it we are probably dust
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RBSH News